Comments

Zentalis Pharma Stock Price, Quotes and Forecasts

ZNTLNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
Q1 2025 Earnings were released on Wed May 14th, before the market open

Zentalis Pharma (ZNTL) Forecast

NewsEarningsZentalis Pharma (ZNTL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Zentalis Pharma Stock Price, Quotes and Forecasts | NASDAQ:ZNTL | Benzinga

Explore Zentalis Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ZNTL.

Open$1.24
Close-
Volume / Avg.359.40K / 852.73K
Day Range$1.21 - $1.29
52 Wk Range1.01 - 13.00
Market Cap$89.58M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
42
Short Interest
10.11%
Days to Cover7.51

Recent News

FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers
The FDA has lifted the partial clinical hold on Zentalis Pharmaceuticals' azenosertib studies. Zentalis plans to work with trial investigators to continue development while presenting additional data later this year.
Vandana Singh
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday?
Zentalis Pharmaceuticals announced the FDA's partial clinical hold on azenosertib studies due to recent patient deaths.
Vandana Singh

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
2
Jan
2
1
Mar
1
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$1.24
Close-
Volume / Avg.359.40K / 852.73K
Day Range$1.21 - $1.29
52 Wk Range1.01 - 13.00
Market Cap$89.58M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
42
Short Interest
10.11%
Days to Cover7.51
About Zentalis Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (Z...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ZNTL
MGNX

FAQ

Q

How do I buy Zentalis Pharma (ZNTL) stock?

A

You can purchase shares of Zentalis Pharma (NASDAQ:ZNTL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Zentalis Pharma (ZNTL) competitors?

A

Other companies in Zentalis Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), OncoCyte (NASDAQ:OCX) and Elicio Therapeutics (NASDAQ:ELTX).

Q

What is the forecast, or price target, for Zentalis Pharma (ZNTL) stock?

A

Zentalis Pharma has a consensus price target of $15.93.

Q

What is the current price for Zentalis Pharma (ZNTL)?

A

The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $1.245 last updated May 19, 2025 at 1:30 PM EDT.

Q

Does Zentalis Pharma (ZNTL) pay a dividend?

A

There are no upcoming dividends for Zentalis Pharma.

Q

When is Zentalis Pharma (NASDAQ:ZNTL) reporting earnings?

A

Zentalis Pharma’s Q2 earnings are confirmed for Friday, August 8, 2025.

Q

Is Zentalis Pharma (ZNTL) going to split?

A

There is no upcoming split for Zentalis Pharma.

Q

What sector and industry does Zentalis Pharma (ZNTL) operate in?

A

Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved